NI200900165A - Estabilización de vitamina b12 - Google Patents
Estabilización de vitamina b12Info
- Publication number
- NI200900165A NI200900165A NI200900165A NI200900165A NI200900165A NI 200900165 A NI200900165 A NI 200900165A NI 200900165 A NI200900165 A NI 200900165A NI 200900165 A NI200900165 A NI 200900165A NI 200900165 A NI200900165 A NI 200900165A
- Authority
- NI
- Nicaragua
- Prior art keywords
- vitamin
- stabilization
- preparation
- butanol
- medicament
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La invención se refiere a una preparación que contiene vitamina B12 y butanol. El uso de una preparación de este tipo para la preparación de un medicamento. El uso de butanol para la estabilización de vitamina B12. El uso de butanol para la preparación de preparaciones de vitamina B12 con mejor estabilidad para la vitamina B12.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102007012644A DE102007012644A1 (de) | 2007-03-16 | 2007-03-16 | Stabilisierung von Vitamin B12 |
Publications (1)
Publication Number | Publication Date |
---|---|
NI200900165A true NI200900165A (es) | 2010-09-23 |
Family
ID=39688186
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NI200900165A NI200900165A (es) | 2007-03-16 | 2009-09-08 | Estabilización de vitamina b12 |
Country Status (32)
Country | Link |
---|---|
US (3) | US20080261914A1 (es) |
EP (1) | EP2121024B1 (es) |
JP (1) | JP5558838B2 (es) |
KR (1) | KR101508602B1 (es) |
CN (1) | CN101631564B (es) |
AU (1) | AU2008228597B2 (es) |
BR (2) | BRPI0808979B8 (es) |
CA (1) | CA2680756C (es) |
CO (1) | CO6231001A2 (es) |
CR (1) | CR11018A (es) |
DE (1) | DE102007012644A1 (es) |
DK (1) | DK2121024T3 (es) |
DO (1) | DOP2009000213A (es) |
EC (1) | ECSP099616A (es) |
ES (1) | ES2560102T3 (es) |
GT (1) | GT200900240A (es) |
HK (1) | HK1138198A1 (es) |
HR (1) | HRP20160048T1 (es) |
HU (1) | HUE026554T2 (es) |
IL (1) | IL200499A (es) |
MX (1) | MX2009009439A (es) |
MY (1) | MY154485A (es) |
NI (1) | NI200900165A (es) |
NZ (1) | NZ579627A (es) |
PL (1) | PL2121024T3 (es) |
PT (1) | PT2121024E (es) |
RU (1) | RU2472528C2 (es) |
SI (1) | SI2121024T1 (es) |
SV (1) | SV2009003366A (es) |
UA (1) | UA97141C2 (es) |
WO (1) | WO2008113483A2 (es) |
ZA (1) | ZA200905974B (es) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102008022520A1 (de) * | 2008-05-07 | 2009-11-12 | Bayer Animal Health Gmbh | Feste Arzneimittelformulierung mit verzögerter Freisetzung |
BR112013010049B1 (pt) * | 2010-10-29 | 2021-07-13 | Troikaa Pharmaceuticals Ltd. | Composições nasais da vitamina b12 |
CA2868343A1 (en) * | 2011-03-24 | 2012-09-27 | Seachaid Pharmaceuticals, Inc. | Vancomycin derivatives |
DK2849764T3 (da) * | 2012-05-14 | 2019-08-19 | Warburton Technology Ltd | Sporstofopløsning |
KR101400791B1 (ko) * | 2012-10-04 | 2014-05-29 | 주식회사대성미생물연구소 | 동물용 복합 기능성 항생제 조성물 |
CN102908354A (zh) * | 2012-11-02 | 2013-02-06 | 青岛康地恩药业股份有限公司 | 一种布他磷注射液的制备方法 |
RU2529814C1 (ru) * | 2013-05-20 | 2014-09-27 | Федеральное государственное бюджетное учреждение "Научный центр экспертизы средств медицинского применения" Министерства здравоохранения Российской Федерации | Способ определения подлинности и количественного содержания бензэтония хлорида в лекарственных препаратах |
WO2016199165A2 (en) * | 2015-06-08 | 2016-12-15 | Zim Laboratories Limited | Improved mucosal delivery of vitamin b12 |
DE102018005078A1 (de) | 2018-06-26 | 2020-01-02 | Ilma biochem GmbH | Verfahren zur Herstellung und Zusammensetzung von stabilisierten Cob(II)alamin- und Cob(II)inamide-Lösungen als Ausgangszubereitungen zur Herstellung von Arzneimitteln, Medizinprodukten, Nahrungsergänzungsmitteln und Kosmetika |
KR102058133B1 (ko) * | 2019-02-22 | 2019-12-20 | 우진 비앤지 주식회사 | 혼합제제 내 항생제 용해도를 향상시킬 수 있는 면역 증강용 조성물 및 이의 용도 |
JP7270465B2 (ja) * | 2019-05-31 | 2023-05-10 | 小林製薬株式会社 | ビタミンb12類の光安定化方法 |
JP7368108B2 (ja) * | 2019-05-31 | 2023-10-24 | 小林製薬株式会社 | 水性組成物 |
JP2020196672A (ja) * | 2019-05-31 | 2020-12-10 | 小林製薬株式会社 | ビタミンb12類含有組成物 |
NZ785052A (en) * | 2019-07-12 | 2022-08-26 | Chemvet Australia Pty Ltd | Injectable nutritional supplement |
WO2023198854A1 (en) * | 2022-04-14 | 2023-10-19 | Dsm Ip Assets B.V. | Novel use of psicose |
Family Cites Families (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2579679A (en) | 1949-09-22 | 1951-12-25 | Abbott Lab | Stable vitamin b12 composition |
US2566123A (en) | 1949-09-22 | 1951-08-28 | Abbott Lab | Stable vitamin b12 solution |
GB692968A (en) | 1950-08-12 | 1953-06-17 | Organon Nv | Process for the manufacture of stable preparations of vitamins of the b group |
US2662048A (en) | 1950-12-19 | 1953-12-08 | Walter A Winsten | Stable vitamin b12-containing composition |
US2748054A (en) | 1951-10-16 | 1956-05-29 | Olin Mathieson | Stable vitamin b12 and soluble folic acid salt mixture |
US2778771A (en) | 1952-05-16 | 1957-01-22 | American Cyanamid Co | Stabilizing of vitamin b12 solutions |
DE951162C (de) * | 1953-08-15 | 1956-10-25 | Aschaffenburger Zellstoffwerke | Reinigung und Trennung von Vitaminen der B-Gruppe durch Adsorptionschromatographie |
DE1052637B (de) | 1956-05-03 | 1959-03-12 | Merck Ag E | Verfahren zur Herstellung von haltbaren Vitamin-B-Kombinationspraeparaten in Kapselform |
GB822127A (en) | 1957-11-25 | 1959-10-21 | Vitarine Company Inc | Stabilized multivitamin compositions containing vitamin b |
FR1285213A (fr) | 1958-01-13 | 1962-02-23 | Vitarine Company | Procédé de stabilisation de vitamine b12 |
FR1263794A (fr) | 1959-01-30 | 1961-06-19 | Ile De Rech S Scient Et Ind So | Procédé de fabrication de solutions aqueuses stables et stérilisables, de vitamines |
ES247522A1 (es) | 1959-02-24 | 1959-06-16 | Garci Alejo Del Valle Rodrigo | Nuevo procedimiento para la consecuciën de una asociaciën de cianocobalamina a las sales organicas de calcio |
BE576619A (fr) | 1959-03-12 | 1959-07-01 | Belgo Canadienne Continental P | Procédé de préparation de solutions injectables stables de vitamines B1 et B12 en melange et solutions obtenues. |
US2939821A (en) | 1959-09-21 | 1960-06-07 | U S Vitamin And Pharmaceutical | Stable solutions containing vitamin b12 |
GB902377A (en) | 1960-05-30 | 1962-08-01 | U S Vitamins & Pharmaceutical | Stable solutions containing vitamin b |
JPS4310862Y1 (es) | 1964-11-30 | 1968-05-11 | ||
DE2522187C2 (de) | 1975-05-17 | 1977-10-28 | Byk Gulden Lomberg Chem Fab | Verwendung von Cystein oder dessen Säureadditionssalz und Natriumdisulfit zur Stabilisierung von injizierbaren, einen pH-Wert zwischen 7 und 9 aufweisenden, Vitamin B tief 12 und nichtsteroidal Entzündungshemmer enthaltenden Arzneimitteln |
CH630532A5 (de) | 1977-08-18 | 1982-06-30 | Tmc Corp | Skibremse. |
JPS597685B2 (ja) | 1978-10-06 | 1984-02-20 | 理研ビタミン株式会社 | ビタミン製剤の製造法 |
ZA837627B (en) * | 1982-10-15 | 1984-06-27 | Procter & Gamble | Storage stable topical pharmaceutical composition containing low dielectric solvents |
AT376879B (de) | 1982-10-27 | 1985-01-10 | Gerot Pharmazeutika | Verfahren zur herstellung einer injektionsloesung |
JPS6129641A (ja) | 1984-07-23 | 1986-02-10 | Matsushita Electric Ind Co Ltd | 二温度加熱貯湯装置 |
JPS63313736A (ja) | 1987-06-15 | 1988-12-21 | Nippon Kayaku Co Ltd | 総合ビタミン凍結乾燥製剤 |
JPS6411864U (es) | 1987-07-13 | 1989-01-23 | ||
EP0297537A3 (en) | 1987-06-30 | 1989-05-10 | Nippon Seiko Kabushiki Kaisha | Webbing retractor |
JPS6448780A (en) | 1987-08-19 | 1989-02-23 | Hitachi Ltd | Paper sheet accumulating device |
JPH02145521A (ja) | 1988-11-29 | 1990-06-05 | Zeria Pharmaceut Co Ltd | 安定な点眼剤 |
JP2822058B2 (ja) | 1989-05-29 | 1998-11-05 | ゼリア新薬工業株式会社 | 安定な点眼剤 |
ATE86111T1 (de) * | 1989-08-31 | 1993-03-15 | Takeda Chemical Industries Ltd | Vitamin-b12-zusammensetzung. |
JPH049239A (ja) | 1990-04-24 | 1992-01-14 | Nippon Steel Corp | 微細金属線の切断方法 |
JP3061062B2 (ja) | 1990-06-18 | 2000-07-10 | エーザイ株式会社 | ビタミンb▲下1▼▲下2▼の光安定化方法及びビタミンb▲下1▼▲下2▼を含有する医薬組成物 |
JPH04107474A (ja) | 1990-08-28 | 1992-04-08 | Tokyo Electric Co Ltd | 電子写真装置 |
JPH04235925A (ja) | 1991-01-11 | 1992-08-25 | Otsuka Pharmaceut Co Ltd | 安定な総合ビタミン注射液 |
JPH05247800A (ja) | 1991-02-27 | 1993-09-24 | Fukuhara Seiki Seisakusho:Kk | 丸編機における編地幅の調整方法 |
JPH0515368A (ja) | 1991-07-05 | 1993-01-26 | Nagase Seikagaku Kogyo Kk | 新規プルラナーゼおよびその製造方法 |
JP3155312B2 (ja) | 1991-11-05 | 2001-04-09 | 同仁医薬化工株式会社 | 安定な静脈注射用総合ビタミン剤 |
JPH06124286A (ja) | 1992-10-12 | 1994-05-06 | Mitsubishi Electric Corp | 稼働率測定装置 |
US6461622B2 (en) | 1994-09-07 | 2002-10-08 | Johnson & Johnson Consumer Companies, Inc. | Topical compositions |
US5976555A (en) * | 1994-09-07 | 1999-11-02 | Johnson & Johnson Consumer Products, Inc. | Topical oil-in-water emulsions containing retinoids |
JP2000095676A (ja) * | 1998-09-21 | 2000-04-04 | Tokai Capsule Kk | ビタミンb12含有ソフトカプセル剤 |
JP4477161B2 (ja) | 1999-05-13 | 2010-06-09 | テルモ株式会社 | ビタミン含有液 |
JP4753448B2 (ja) | 1999-08-10 | 2011-08-24 | ライオン株式会社 | パルミチン酸レチノール、レチノールの安定化方法及びビタミン類水溶液 |
HU226322B1 (hu) * | 2000-07-04 | 2008-08-28 | Medveritas Intellectual Proper | Adalékkompozíció zsírban oldódó vitaminok vizes stabilizálására, az így elõállított készítmények, valamint azok alkalmazhatósága különbözõ területeken |
JP4049239B2 (ja) | 2000-08-30 | 2008-02-20 | Tdk株式会社 | 表面弾性波素子を含む高周波モジュール部品の製造方法 |
JP2004235925A (ja) | 2003-01-30 | 2004-08-19 | Hitachi Ltd | 誤り訂正方法、誤り訂正回路および情報記録再生装置 |
JP2005015368A (ja) | 2003-06-25 | 2005-01-20 | Saga Seiyaku Kk | プラノプロフェン含有水性液剤の安定化方法 |
DE10329716A1 (de) * | 2003-07-02 | 2005-01-20 | Bayer Healthcare Ag | Verbesserung der Schlupffähigkeit bei eierlegenden Tieren |
JP4355796B2 (ja) * | 2003-08-29 | 2009-11-04 | 国立大学法人京都大学 | 有機半導体装置およびその製造方法 |
US20050074443A1 (en) | 2003-10-03 | 2005-04-07 | Treadwell Benjamin V. | Methods of attenuating autoimmune disease and compositions useful therefor |
JP2005247800A (ja) | 2004-03-08 | 2005-09-15 | Zeria Pharmaceut Co Ltd | 点眼剤 |
WO2005094842A1 (en) | 2004-03-30 | 2005-10-13 | Transition Therapeutics Inc. | Vitamin b12-containing compositions and methods of use |
CN101084016A (zh) * | 2004-04-15 | 2007-12-05 | 克艾思马有限公司 | 能够容易穿透生物学障碍的组合物 |
JP4329632B2 (ja) | 2004-06-23 | 2009-09-09 | ウシオ電機株式会社 | 紫外光照射装置 |
JP2006124286A (ja) | 2004-10-26 | 2006-05-18 | Otsuka Pharmaceut Factory Inc | 総合輸液製剤 |
US20060120967A1 (en) * | 2004-12-07 | 2006-06-08 | Qpharma, Llc | Solution forms of cyclodextrins for nasal or throat delivery of essential oils |
-
2007
- 2007-03-16 DE DE102007012644A patent/DE102007012644A1/de not_active Withdrawn
-
2008
- 2008-03-07 KR KR1020097019154A patent/KR101508602B1/ko active IP Right Grant
- 2008-03-07 MX MX2009009439A patent/MX2009009439A/es active IP Right Grant
- 2008-03-07 BR BRPI0808979A patent/BRPI0808979B8/pt active IP Right Grant
- 2008-03-07 ES ES08716334.1T patent/ES2560102T3/es active Active
- 2008-03-07 CN CN200880008418XA patent/CN101631564B/zh active Active
- 2008-03-07 WO PCT/EP2008/001819 patent/WO2008113483A2/de active Application Filing
- 2008-03-07 AU AU2008228597A patent/AU2008228597B2/en active Active
- 2008-03-07 PL PL08716334T patent/PL2121024T3/pl unknown
- 2008-03-07 DK DK08716334.1T patent/DK2121024T3/en active
- 2008-03-07 JP JP2009553947A patent/JP5558838B2/ja active Active
- 2008-03-07 MY MYPI20093766A patent/MY154485A/en unknown
- 2008-03-07 RU RU2009138047/15A patent/RU2472528C2/ru active
- 2008-03-07 SI SI200831569T patent/SI2121024T1/sl unknown
- 2008-03-07 EP EP08716334.1A patent/EP2121024B1/de active Active
- 2008-03-07 CA CA2680756A patent/CA2680756C/en active Active
- 2008-03-07 NZ NZ579627A patent/NZ579627A/en unknown
- 2008-03-07 PT PT87163341T patent/PT2121024E/pt unknown
- 2008-03-07 UA UAA200910462A patent/UA97141C2/ru unknown
- 2008-03-07 HU HUE08716334A patent/HUE026554T2/en unknown
- 2008-03-07 BR BR122019021714A patent/BR122019021714B8/pt active IP Right Grant
- 2008-03-11 US US12/045,831 patent/US20080261914A1/en not_active Abandoned
-
2009
- 2009-08-20 IL IL200499A patent/IL200499A/en active IP Right Grant
- 2009-08-28 ZA ZA2009/05974A patent/ZA200905974B/en unknown
- 2009-09-04 CO CO09094516A patent/CO6231001A2/es active IP Right Grant
- 2009-09-07 GT GT200900240A patent/GT200900240A/es unknown
- 2009-09-07 SV SV2009003366A patent/SV2009003366A/es unknown
- 2009-09-07 DO DO2009000213A patent/DOP2009000213A/es unknown
- 2009-09-08 NI NI200900165A patent/NI200900165A/es unknown
- 2009-09-08 EC EC2009009616A patent/ECSP099616A/es unknown
- 2009-09-08 CR CR11018A patent/CR11018A/es unknown
-
2010
- 2010-04-30 HK HK10104307.8A patent/HK1138198A1/xx unknown
- 2010-11-22 US US12/951,581 patent/US9089582B2/en active Active
-
2015
- 2015-07-24 US US14/808,425 patent/US9610297B2/en active Active
-
2016
- 2016-01-15 HR HRP20160048TT patent/HRP20160048T1/hr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NI200900165A (es) | Estabilización de vitamina b12 | |
CL2008003690A1 (es) | Compuestos derivados de amonobenzamida; composicion farmceutica que comprende los compuestos; y uso para controlar parasitos. | |
SV2018005778A (es) | Derivados aromaticos de sulfonamida | |
DOP2015000264A (es) | Derivados de azaadamantano y métodos de uso de los mismos | |
HN2010002478A (es) | Derivados de indazol sustituidos con fenilo y benzodioxinilo | |
GT201400230A (es) | Necleòsidos de espìrooxetano de uracilo | |
CL2013003313A1 (es) | Compuestos derivados de 2,4-diaminoquinazolinas, sales o solvatos farmacéuticamente aceptables; composición farmacéutica que los comprende; y uso en el tratamiento de un trastorno en el que interviene la modulación de tlr7 y/o tlr8. | |
GT201200165A (es) | Triazolopiridinas | |
CL2013001338A1 (es) | Compuestos derivados de benzotieno-piridinas sustituidas, inhibidores de la replicacion del vih; composicion farmaceutica que los comprende; combinacion farmaceutica; kit farmaceutico; y su uso para el tratamiento del vih. | |
BRPI0809667A2 (pt) | Composto, medicamento e composição farmacêutica que o contém e uso do composto | |
AR077629A1 (es) | Mimetico de smac | |
BRPI0814593A2 (pt) | Composto, composição farmacêutica que o contém e uso do composto. | |
CL2011000214A1 (es) | Composicion farmaceutica que comprende progesterona micronizada y aceite de cartamo tipo ii; y uso para el tratamiento de una condicion relacionada con la insuficiencia de secrecion de progesterona. | |
GT201000047A (es) | Mejoras en compuestos organicos o relacionadas con los mismos | |
CL2008001123A1 (es) | Compuestos derivados de acido lipoico; formulacion farmaceutica que lo comprende; y uso en el tratamiento del cancer. | |
CU20120002A7 (es) | DERIVADOS DE 1-(5,6-DIHIDROIMIDAZO(1,2-a)PIRAZIN-7(8H)-IL )ETANONA | |
CL2008002049A1 (es) | Compuestos derivados de aminoindol macrociclicos; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de la hepatitis c. | |
CO6640301A2 (es) | Compuestos ologo-benzamida y su uso | |
BRPI0916571A2 (pt) | composto derivado de alquilaminometiloxazolidinona tricíclo, medicamento e composição farmacêutica que o contém e uso do composto | |
CL2012003265A1 (es) | Polisacarido de semillas de tamarindo para usarse en el tratamiento de enfermedades infecciosas; composicion farmacéutica y/o dermocosmética antiinflamatoria que contiene dicho polisacárido; uso de un polisacárido de semilla de tamarindo. | |
BRPI0815455C1 (pt) | compostos derivados de n-fenilacetamida, composição farmacêutica, composição cosmética, uso cosmético de uma composição, e usos de um composto do mesmo | |
BR112015022484A2 (pt) | formulações com oxidação reduzida | |
CL2012001641A1 (es) | Compuestos derivados de piperazina; composición farmacéutica; que comprende a uno de los compuestos y uso de los compuestos en la preparación de medicamentos para el tratamiento y/o prevención de infecciones por protozoos, en forma particular para el tratamiento y/o prevención de la malaria. | |
BR112015022475A2 (pt) | formulações com oxidação reduzida | |
BR112015015202B8 (pt) | Composição |